259 related articles for article (PubMed ID: 19772377)
1. Controlled release polymeric ocular delivery of acyclovir.
Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
[TBL] [Abstract][Full Text] [Related]
2. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/poly(amidoamine) copolymer.
Bencini M; Ranucci E; Ferruti P; Trotta F; Donalisio M; Cornaglia M; Lembo D; Cavalli R
J Control Release; 2008 Feb; 126(1):17-25. PubMed ID: 18079013
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of sponge-like acyclovir ocular minitablets.
Refai H; Tag R
Drug Deliv; 2011 Jan; 18(1):38-45. PubMed ID: 20804440
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
7. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
8. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
9. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Aug; 320(1-2):53-7. PubMed ID: 16701974
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
11. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
Prasad Verma PR; Chandak AR
Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
[TBL] [Abstract][Full Text] [Related]
12. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation.
Sultana Y; Aqil M; Ali A
Acta Pharm; 2005 Sep; 55(3):305-14. PubMed ID: 16375841
[TBL] [Abstract][Full Text] [Related]
13. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
14. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
Ribeiro L; Ferreira DC; Veiga FJ
J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617
[TBL] [Abstract][Full Text] [Related]
15. Influence of hydroxypropyl methylcellulose on drug release pattern of a gastroretentive floating drug delivery system using a 3(2) full factorial design.
Swain K; Pattnaik S; Mallick S; Chowdary KA
Pharm Dev Technol; 2009; 14(2):193-8. PubMed ID: 19519191
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
17. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
Karavas E; Georgarakis E; Bikiaris D
Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
[TBL] [Abstract][Full Text] [Related]
18. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery.
Bozkir A; Denli ZF; Basaran B
Acta Pol Pharm; 2012; 69(4):719-24. PubMed ID: 22876616
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
